BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O’Connor JP, Rose CJ, Jackson A, Watson Y, Cheung S, Maders F, Whitcher BJ, Roberts C, Buonaccorsi GA, Thompson G. DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. Br J Cancer. 2011;105:139-145. [PMID: 21673686 DOI: 10.1038/bjc.2011.191] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 9.9] [Reference Citation Analysis]
Number Citing Articles
1 Franklin JM, Irving B, Papiez BW, Kallehauge JF, Wang LM, Goldin RD, Harris AL, Anderson EM, Schnabel JA, Chappell MA, Brady M, Sharma RA, Gleeson FV. Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: Comparison with histological subregions and impact on pharmacokinetic parameter analysis. Eur J Radiol 2020;126:108934. [PMID: 32217426 DOI: 10.1016/j.ejrad.2020.108934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ueno Y, Forghani B, Forghani R, Dohan A, Zeng XZ, Chamming's F, Arseneau J, Fu L, Gilbert L, Gallix B, Reinhold C. Endometrial Carcinoma: MR Imaging-based Texture Model for Preoperative Risk Stratification-A Preliminary Analysis. Radiology. 2017;284:748-757. [PMID: 28493790 DOI: 10.1148/radiol.2017161950] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 15.4] [Reference Citation Analysis]
3 Bhushan M, Schnabel JA, Chappell M, Gleeson F, Anderson M, Franklin J, Brady SM, Jenkinson M. The Impact of Heterogeneity and Uncertainty on Prediction of Response to Therapy Using Dynamic MRI Data. In: Salinesi C, Norrie MC, Pastor Ó, editors. Advanced Information Systems Engineering. Berlin: Springer Berlin Heidelberg; 2013. pp. 316-23. [DOI: 10.1007/978-3-642-40811-3_40] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Pellino G, Gallo G, Pallante P, Capasso R, De Stefano A, Maretto I, Malapelle U, Qiu S, Nikolaou S, Barina A, Clerico G, Reginelli A, Giuliani A, Sciaudone G, Kontovounisios C, Brunese L, Trompetto M, Selvaggi F. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives. Gastroenterol Res Pract. 2018;2018:2397863. [PMID: 30008744 DOI: 10.1155/2018/2397863] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
5 Baker JH, McPhee KC, Moosvi F, Saatchi K, Häfeli UO, Minchinton AI, Reinsberg SA. Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG-GdF). Contrast Media Mol Imaging 2016;11:77-88. [PMID: 26268906 DOI: 10.1002/cmmi.1661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Haney CR, Fan X, Markiewicz E, Mustafi D, Karczmar GS, Stadler WM. Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis. Technol Cancer Res Treat 2013;12:71-8. [PMID: 22905809 DOI: 10.7785/tcrt.2012.500255] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
7 Lee JM, Yoon JH, Kim KW. Diagnosis of hepatocellular carcinoma: newer radiological tools. Semin Oncol. 2012;39:399-409. [PMID: 22846858 DOI: 10.1053/j.seminoncol.2012.05.010] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
8 Li X, Arlinghaus LR, Ayers GD, Chakravarthy AB, Abramson RG, Abramson VG, Atuegwu N, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Bhave SR, Yankeelov TE. DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Magn Reson Med 2014;71:1592-602. [PMID: 23661583 DOI: 10.1002/mrm.24782] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 7.7] [Reference Citation Analysis]
9 Kim JH, Lee JM, Park JH, Kim SC, Joo I, Han JK, Choi BI. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study. Radiology. 2013;266:185-196. [PMID: 23192779 DOI: 10.1148/radiol.12120111] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
10 Drisis S, El Adoui M, Flamen P, Benjelloun M, Dewind R, Paesmans M, Ignatiadis M, Bali M, Lemort M. Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRI. J Magn Reson Imaging 2020;51:1403-11. [PMID: 31737963 DOI: 10.1002/jmri.26996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Chen L, Choyke PL, Wang N, Clarke R, Bhujwalla ZM, Hillman EM, Wang G, Wang Y. Unsupervised deconvolution of dynamic imaging reveals intratumor vascular heterogeneity and repopulation dynamics. PLoS One 2014;9:e112143. [PMID: 25379705 DOI: 10.1371/journal.pone.0112143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Barnes SL, Whisenant JG, Loveless ME, Ayers GD, Yankeelov TE. Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer. Magn Reson Med 2013;69:1721-34. [PMID: 22847762 DOI: 10.1002/mrm.24422] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
13 Thomas JV, Abou Elkassem AM, Ganeshan B, Smith AD. MR Imaging Texture Analysis in the Abdomen and Pelvis. Magn Reson Imaging Clin N Am 2020;28:447-56. [PMID: 32624161 DOI: 10.1016/j.mric.2020.03.009] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hu N, Yin S, Li Q, He H, Zhong L, Gong NJ, Guo J, Cai P, Xie C, Liu H, Qiu B. Evaluating Heterogeneity of Primary Lung Tumor Using Clinical Routine Magnetic Resonance Imaging and a Tumor Heterogeneity Index. Front Oncol 2020;10:591485. [PMID: 33542900 DOI: 10.3389/fonc.2020.591485] [Reference Citation Analysis]
15 Reyners AK, Broekman KE, Glaudemans AW, Brouwers AH, Arts HJ, van der Zee AG, de Vries EG, Jalving M. Molecular imaging in ovarian cancer. Ann Oncol 2016;27 Suppl 1:i23-9. [PMID: 27141066 DOI: 10.1093/annonc/mdw091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Scalco E, Rizzo G. Texture analysis of medical images for radiotherapy applications. Br J Radiol 2017;90:20160642. [PMID: 27885836 DOI: 10.1259/bjr.20160642] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
17 Granata V, Fusco R, Avallone A, Catalano O, Piccirillo M, Palaia R, Nasti G, Petrillo A, Izzo F. A radiologist's point of view in the presurgical and intraoperative setting of colorectal liver metastases. Future Oncol 2018;14:2189-206. [PMID: 30084273 DOI: 10.2217/fon-2018-0080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
18 Gourtsoyianni S, Doumou G, Prezzi D, Taylor B, Stirling JJ, Taylor NJ, Siddique M, Cook GJR, Glynne-Jones R, Goh V. Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture Features. Radiology 2017;284:552-61. [PMID: 28481194 DOI: 10.1148/radiol.2017161375] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
19 Di Giovanni P, Ahearn TS, Semple SIK, Lovell LM, Miller I, Gilbert FJ, Redpath TW, Heys SD, Staff RT. The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat 2012;133:1199-206. [DOI: 10.1007/s10549-012-2014-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
20 Parekh V, Jacobs MA. Radiomics: a new application from established techniques. Expert Rev Precis Med Drug Dev 2016;1:207-26. [PMID: 28042608 DOI: 10.1080/23808993.2016.1164013] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 20.8] [Reference Citation Analysis]
21 Simpson AL, Adams LB, Allen PJ, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Leung U, Miga MI, Parada EP, Jarnagin WR, Do RK. Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. J Am Coll Surg. 2015;220:339-346. [PMID: 25537305 DOI: 10.1016/j.jamcollsurg.2014.11.027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
22 Van Cutsem E, Verheul HM, Flamen P, Rougier P, Beets-Tan R, Glynne-Jones R, Seufferlein T. Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians. Cancers (Basel). 2016;8. [PMID: 27589804 DOI: 10.3390/cancers8090081] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
23 Fowkes LA, Koh DM, Collins DJ, Jerome NP, MacVicar D, Chua SC, Pearson AD. Childhood extracranial neoplasms: the role of imaging in drug development and clinical trials. Pediatr Radiol 2015;45:1600-15. [PMID: 26045035 DOI: 10.1007/s00247-015-3342-8] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Wetz C, Genseke P, Apostolova I, Furth C, Ghazzawi S, Rogasch JMM, Schatka I, Kreissl MC, Hofheinz F, Grosser OS, Amthauer H. The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE. PLoS One 2019;14:e0216781. [PMID: 31091247 DOI: 10.1371/journal.pone.0216781] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Kushchayev SV, Kushchayeva YS, Tella SH, Glushko T, Pacak K, Teytelboym OM. Medullary Thyroid Carcinoma: An Update on Imaging. J Thyroid Res 2019;2019:1893047. [PMID: 31360432 DOI: 10.1155/2019/1893047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
26 Han Y, Chai F, Wei J, Yue Y, Cheng J, Gu D, Zhang Y, Tong T, Sheng W, Hong N, Ye Y, Wang Y, Tian J. Identification of Predominant Histopathological Growth Patterns of Colorectal Liver Metastasis by Multi-Habitat and Multi-Sequence Based Radiomics Analysis. Front Oncol 2020;10:1363. [PMID: 32923388 DOI: 10.3389/fonc.2020.01363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Dominietto M, Rudin M. Could magnetic resonance provide in vivo histology? Front Genet 2014;4:298. [PMID: 24454320 DOI: 10.3389/fgene.2013.00298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
28 Kim YE, Joo B, Park MS, Shin SJ, Ahn JB, Kim MJ. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial. Cancer Res Treat. 2016;48:1210-1221. [PMID: 26987390 DOI: 10.4143/crt.2015.374] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
29 Sennino B, McDonald DM. Controlling escape from angiogenesis inhibitors. Nat Rev Cancer 2012;12:699-709. [PMID: 23001349 DOI: 10.1038/nrc3366] [Cited by in Crossref: 172] [Cited by in F6Publishing: 166] [Article Influence: 17.2] [Reference Citation Analysis]
30 Thomassin-naggara I, Soualhi N, Balvay D, Darai E, Cuenod C. Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: A preliminary study: Adnexal Tumor Vascular Heterogeneity. J Magn Reson Imaging 2017;46:1776-85. [DOI: 10.1002/jmri.25707] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
31 Thibodeau-Antonacci A, Petitclerc L, Gilbert G, Bilodeau L, Olivié D, Cerny M, Castel H, Turcotte S, Huet C, Perreault P, Soulez G, Chagnon M, Kadoury S, Tang A. Dynamic contrast-enhanced MRI to assess hepatocellular carcinoma response to Transarterial chemoembolization using LI-RADS criteria: A pilot study. Magn Reson Imaging 2019;62:78-86. [PMID: 31247250 DOI: 10.1016/j.mri.2019.06.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
32 Cheng J, Qiu M, Zhang Y, Hong N, Shen D, Zhou J, Wang Y. Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy. AJR Am J Roentgenol 2020;215:1377-83. [PMID: 32991216 DOI: 10.2214/AJR.19.22280] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Wang X, Wang Y, Zhang Z, Zhou M, Zhou X, Zhao H, Xing J, Zhou Y. Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX. Eur J Radiol 2021;143:109887. [PMID: 34454297 DOI: 10.1016/j.ejrad.2021.109887] [Reference Citation Analysis]
34 Hatt M, Tixier F, Pierce L, Kinahan PE, Le Rest CC, Visvikis D. Characterization of PET/CT images using texture analysis: the past, the present… any future? Eur J Nucl Med Mol Imaging 2017;44:151-65. [PMID: 27271051 DOI: 10.1007/s00259-016-3427-0] [Cited by in Crossref: 257] [Cited by in F6Publishing: 221] [Article Influence: 42.8] [Reference Citation Analysis]
35 Alic L, Niessen WJ, Veenland JF. Quantification of heterogeneity as a biomarker in tumor imaging: a systematic review. PLoS One 2014;9:e110300. [PMID: 25330171 DOI: 10.1371/journal.pone.0110300] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 11.6] [Reference Citation Analysis]
36 De Robertis R, Tinazzi Martini P, Demozzi E, Puntel G, Ortolani S, Cingarlini S, Ruzzenente A, Guglielmi A, Tortora G, Bassi C, Pederzoli P, D’Onofrio M. Prognostication and response assessment in liver and pancreatic tumors: The new imaging. World J Gastroenterol 2015; 21(22): 6794-6808 [PMID: 26078555 DOI: 10.3748/wjg.v21.i22.6794] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
37 Tao X, Wang L, Hui Z, Liu L, Ye F, Song Y, Tang Y, Men Y, Lambrou T, Su Z, Xu X, Ouyang H, Wu N. DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLC. Sci Rep 2016;6:35569. [PMID: 27762331 DOI: 10.1038/srep35569] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
38 Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: Practical magnetic resonance imaging approach. World J Hepatol 2015; 7(16): 1987-2008 [PMID: 26261689 DOI: 10.4254/wjh.v7.i16.1987] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
39 Haeck J, Bol K, Bison S, van Tiel S, Koelewijn S, de Jong M, Veenland J, Bernsen M. Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models. Contrast Media Mol Imaging 2015;10:413-20. [PMID: 25995102 DOI: 10.1002/cmmi.1643] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
40 Hagan S, Orr MC, Doyle B. Targeted therapies in colorectal cancer-an integrative view by PPPM. EPMA J 2013;4:3. [PMID: 23356214 DOI: 10.1186/1878-5085-4-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
41 Jayson GC, Hicklin DJ, Ellis LM. Antiangiogenic therapy--evolving view based on clinical trial results. Nat Rev Clin Oncol 2012;9:297-303. [PMID: 22330688 DOI: 10.1038/nrclinonc.2012.8] [Cited by in Crossref: 105] [Cited by in F6Publishing: 90] [Article Influence: 10.5] [Reference Citation Analysis]
42 Asselin MC, O'Connor JP, Boellaard R, Thacker NA, Jackson A. Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer 2012;48:447-55. [PMID: 22265426 DOI: 10.1016/j.ejca.2011.12.025] [Cited by in Crossref: 117] [Cited by in F6Publishing: 103] [Article Influence: 11.7] [Reference Citation Analysis]
43 Wang H, Kaneko OF, Tian L, Hristov D, Willmann JK. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer. Invest Radiol 2015;50:322-9. [PMID: 25575176 DOI: 10.1097/RLI.0000000000000128] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
44 Miyazaki K, Jerome NP, Collins DJ, Orton MR, d'Arcy JA, Wallace T, Moreno L, Pearson AD, Marshall LV, Carceller F, Leach MO, Zacharoulis S, Koh DM. Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study. Eur Radiol 2015;25:2641-50. [PMID: 25773937 DOI: 10.1007/s00330-015-3666-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
45 Ferl GZ, Port RE. Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data. Clin Pharmacol Ther 2012;92:118-24. [PMID: 22588603 DOI: 10.1038/clpt.2012.63] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
46 Ravanelli M, Agazzi GM, Tononcelli E, Roca E, Cabassa P, Baiocchi G, Berruti A, Maroldi R, Farina D. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy. Radiol med 2019;124:877-86. [DOI: 10.1007/s11547-019-01046-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
47 Bol K, Haeck JC, Groen HC, Niessen WJ, Bernsen MR, de Jong M, Veenland JF. Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model? PLoS One 2013;8:e77076. [PMID: 24116203 DOI: 10.1371/journal.pone.0077076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
48 Pitre-Champagnat S, Leguerney I, Bosq J, Peronneau P, Kiessling F, Calmels L, Coulot J, Lassau N. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization. Invest Radiol 2015;50:212-7. [PMID: 25275834 DOI: 10.1097/RLI.0000000000000101] [Cited by in Crossref: 35] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
49 Ciolina M, Caruso D, De Santis D, Zerunian M, Rengo M, Alfieri N, Musio D, De Felice F, Ciardi A, Tombolini V, Laghi A. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment. Radiol Med 2019;124:331-8. [PMID: 30560501 DOI: 10.1007/s11547-018-0978-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
50 Xu HN, Nioka S, Li LZ. Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomark Res 2013;1:6. [PMID: 24252270 DOI: 10.1186/2050-7771-1-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
51 Bundschuh RA, Dinges J, Neumann L, Seyfried M, Zsótér N, Papp L, Rosenberg R, Becker K, Astner ST, Henninger M, Herrmann K, Ziegler SI, Schwaiger M, Essler M. Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer. J Nucl Med 2014;55:891-7. [PMID: 24752672 DOI: 10.2967/jnumed.113.127340] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 10.9] [Reference Citation Analysis]
52 Parikh J, Selmi M, Charles-Edwards G, Glendenning J, Ganeshan B, Verma H, Mansi J, Harries M, Tutt A, Goh V. Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy. Radiology. 2014;272:100-112. [PMID: 24654970 DOI: 10.1148/radiol.14130569] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 10.0] [Reference Citation Analysis]
53 Coenegrachts K, Bols A, Haspeslagh M, Rigauts H. Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: potential of whole tumour ROI and selective ROI analysis. Eur J Radiol. 2012;81:3870-3876. [PMID: 22944331 DOI: 10.1016/j.ejrad.2012.07.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
54 Jones M, Hruby G, Coolens C, Driscoll B, Stanwell P, Kumar M, Capp A, Sridharan S, Arm J, Gallagher S, Holder C, Oldmeadow C, Martin J. A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma. Radiotherapy and Oncology 2020;144:7-12. [DOI: 10.1016/j.radonc.2019.10.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Wang C, Subashi E, Liang X, Yin FF, Chang Z. Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison study. Phys Med Biol 2016;61:4763-80. [PMID: 27272391 DOI: 10.1088/0031-9155/61/13/4763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 O'Connor JP, Rose CJ, Waterton JC, Carano RA, Parker GJ, Jackson A. Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res. 2015;21:249-257. [PMID: 25421725 DOI: 10.1158/1078-0432.ccr-14-0990] [Cited by in Crossref: 319] [Cited by in F6Publishing: 181] [Article Influence: 39.9] [Reference Citation Analysis]
57 Tomaszewski MR, Gillies RJ. The Biological Meaning of Radiomic Features. Radiology. 2021;298:505-516. [PMID: 33399513 DOI: 10.1148/radiol.2021202553] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
58 Beckers RC, Lambregts DM, Lahaye MJ, Rao S, Kleinen K, Grootscholten C, Beets GL, Beets-tan RG, Maas M. Advanced imaging to predict response to chemotherapy in colorectal liver metastases – a systematic review. HPB 2018;20:120-7. [DOI: 10.1016/j.hpb.2017.10.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
59 Colen R, Foster I, Gatenby R, Giger ME, Gillies R, Gutman D, Heller M, Jain R, Madabhushi A, Madhavan S, Napel S, Rao A, Saltz J, Tatum J, Verhaak R, Whitman G. NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures. Transl Oncol. 2014;7:556-569. [PMID: 25389451 DOI: 10.1016/j.tranon.2014.07.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
60 Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, Ganeshan B, Miles KA, Cook GJ, Goh V. Assessment of tumor heterogeneity: An emerging imaging tool for clinical practice? Insights Imaging. 2012;3:573-589. [PMID: 23093486 DOI: 10.1007/s13244-012-0196-6] [Cited by in Crossref: 506] [Cited by in F6Publishing: 456] [Article Influence: 50.6] [Reference Citation Analysis]
61 Michallek F, Dewey M. Fractal analysis in radiological and nuclear medicine perfusion imaging: a systematic review. Eur Radiol 2014;24:60-9. [PMID: 23974703 DOI: 10.1007/s00330-013-2977-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
62 Sadeghi-Naini A, Vorauer E, Chin L, Falou O, Tran WT, Wright FC, Gandhi S, Yaffe MJ, Czarnota GJ. Early detection of chemotherapy-refractory patients by monitoring textural alterations in diffuse optical spectroscopic images. Med Phys 2015;42:6130-46. [PMID: 26520706 DOI: 10.1118/1.4931603] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
63 Russell MR, Graham C, D'Amato A, Gentry-Maharaj A, Ryan A, Kalsi JK, Whetton AD, Menon U, Jacobs I, Graham RLJ. Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel. Br J Cancer 2019;121:483-9. [PMID: 31388184 DOI: 10.1038/s41416-019-0544-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
64 Ricotta R, Vanzulli A, Moroni M, Colnago B, Oriani M, Nichelatti M, Sarnataro C, Venturini F, Di Bella S, Maiolani M, Giganti MO, Sartore-Bianchi A, Siena S. Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab. Clin Colorectal Cancer 2013;12:45-53. [PMID: 23041354 DOI: 10.1016/j.clcc.2012.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
65 Chicklore S, Goh V, Siddique M, Roy A, Marsden PK, Cook GJR. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging 2013;40:133-40. [DOI: 10.1007/s00259-012-2247-0] [Cited by in Crossref: 303] [Cited by in F6Publishing: 276] [Article Influence: 30.3] [Reference Citation Analysis]
66 Kratochvíla J, Jiřík R, Bartoš M, Standara M, Starčuk Z Jr, Taxt T. Distributed capillary adiabatic tissue homogeneity model in parametric multi-channel blind AIF estimation using DCE-MRI. Magn Reson Med 2016;75:1355-65. [PMID: 25865576 DOI: 10.1002/mrm.25619] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
67 Kashyap A, Rapsomaniki MA, Barros V, Fomitcheva-Khartchenko A, Martinelli AL, Rodriguez AF, Gabrani M, Rosen-Zvi M, Kaigala G. Quantification of tumor heterogeneity: from data acquisition to metric generation. Trends Biotechnol 2021:S0167-7799(21)00267-5. [PMID: 34972597 DOI: 10.1016/j.tibtech.2021.11.006] [Reference Citation Analysis]
68 Rose CJ, O'Connor JP, Cootes TF, Taylor CJ, Jayson GC, Parker GJ, Waterton JC. Indexed distribution analysis for improved significance testing of spatially heterogeneous parameter maps: application to dynamic contrast-enhanced MRI biomarkers. Magn Reson Med 2014;71:1299-311. [PMID: 23666778 DOI: 10.1002/mrm.24755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
69 Sanghera B, Banerjee D, Khan A, Simcock I, Stirling JJ, Glynne-Jones R, Goh V. Reproducibility of 2D and 3D fractal analysis techniques for the assessment of spatial heterogeneity of regional blood flow in rectal cancer. Radiology 2012;263:865-73. [PMID: 22438361 DOI: 10.1148/radiol.12111316] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
70 Yang JF, Zhao ZH, Zhang Y, Zhao L, Yang LM, Zhang MM, Wang BY, Wang T, Lu BC. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma. World J Gastroenterol 2016; 22(13): 3652-3662 [PMID: 27053857 DOI: 10.3748/wjg.v22.i13.3652] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
71 Kulkarni NM, Hough DM, Tolat PP, Soloff EV, Kambadakone AR. Pancreatic adenocarcinoma: cross-sectional imaging techniques. Abdom Radiol (NY) 2018;43:253-63. [PMID: 29128993 DOI: 10.1007/s00261-017-1380-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
72 Corona-Villalobos CP, Zhang Y, Zhang WD, Kamel IR. Magnetic resonance imaging of the liver after loco-regional and systemic therapy. Magn Reson Imaging Clin N Am 2014;22:353-72. [PMID: 25086934 DOI: 10.1016/j.mric.2014.04.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
73 Sala E, Mema E, Himoto Y, Veeraraghavan H, Brenton JD, Snyder A, Weigelt B, Vargas HA. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging. Clin Radiol 2017;72:3-10. [PMID: 27742105 DOI: 10.1016/j.crad.2016.09.013] [Cited by in F6Publishing: 130] [Reference Citation Analysis]
74 Werner RA, Lapa C, Ilhan H, Higuchi T, Buck AK, Lehner S, Bartenstein P, Bengel F, Schatka I, Muegge DO, Papp L, Zsótér N, Große-Ophoff T, Essler M, Bundschuh RA. Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity. Oncotarget 2017;8:7039-49. [PMID: 27705948 DOI: 10.18632/oncotarget.12402] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
75 Ensor JE. Biomarker validation: common data analysis concerns. Oncologist 2014;19:886-91. [PMID: 25001264 DOI: 10.1634/theoncologist.2014-0061] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
76 Alobaidli S, McQuaid S, South C, Prakash V, Evans P, Nisbet A. The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning. Br J Radiol 2014;87:20140369. [PMID: 25051978 DOI: 10.1259/bjr.20140369] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
77 Ning J, Sun Y, Xie S, Zhang B, Huang F, Koken P, Smink J, Yuan C, Chen H. Simultaneous acquisition sequence for improved hepatic pharmacokinetics quantification accuracy (SAHA) for dynamic contrast-enhanced MRI of liver. Magn Reson Med 2018;79:2629-41. [PMID: 28905413 DOI: 10.1002/mrm.26915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
78 Cuenod C, Balvay D. Perfusion and vascular permeability: Basic concepts and measurement in DCE-CT and DCE-MRI. Diagnostic and Interventional Imaging 2013;94:1187-204. [DOI: 10.1016/j.diii.2013.10.010] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 14.1] [Reference Citation Analysis]
79 De Bruyne S, Van Damme N, Smeets P, Ferdinande L, Ceelen W, Mertens J, Van de Wiele C, Troisi R, Libbrecht L, Laurent S, Geboes K, Peeters M. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. Br J Cancer 2012;106:1926-33. [PMID: 22596235 DOI: 10.1038/bjc.2012.184] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 8.8] [Reference Citation Analysis]
80 Wang C, Subashi E, Yin FF, Chang Z. Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI. Med Phys 2016;43:1335-47. [PMID: 26936718 DOI: 10.1118/1.4941739] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
81 Morss Clyne A, Swaminathan S, Díaz Lantada A. Biofabrication strategies for creating microvascular complexity. Biofabrication 2019;11:032001. [PMID: 30743247 DOI: 10.1088/1758-5090/ab0621] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
82 Hill EJ, Roberts C, Franklin JM, Enescu M, West N, MacGregor TP, Chu KY, Boyle L, Blesing C, Wang LM, Mukherjee S, Anderson EM, Brown G, Dutton S, Love SB, Schnabel JA, Quirke P, Muschel R, McKenna WG, Partridge M, Sharma RA. Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer. Clin Cancer Res 2016;22:1922-31. [PMID: 26861457 DOI: 10.1158/1078-0432.CCR-15-1489] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
83 Ashraf AB, Daye D, Gavenonis S, Mies C, Feldman M, Rosen M, Kontos D. Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. Radiology. 2014;272:374-384. [PMID: 24702725 DOI: 10.1148/radiol.14131375] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 12.5] [Reference Citation Analysis]
84 Li X, Abramson RG, Arlinghaus LR, Chakravarthy AB, Abramson V, Mayer I, Farley J, Delbeke D, Yankeelov TE. An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results. EJNMMI Res 2012;2:62. [PMID: 23157877 DOI: 10.1186/2191-219X-2-62] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
85 Thüring J, Kuhl CK, Barabasch A, Hitpass L, Bode M, Bünting N, Bruners P, Krämer NA. Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker? PLoS One 2020;15:e0230553. [PMID: 32231380 DOI: 10.1371/journal.pone.0230553] [Reference Citation Analysis]
86 Berks M, Little RA, Watson Y, Cheung S, Datta A, O'Connor JPB, Scaramuzza D, Parker GJM. A model selection framework to quantify microvascular liver function in gadoxetate-enhanced MRI: Application to healthy liver, diseased tissue, and hepatocellular carcinoma. Magn Reson Med 2021;86:1829-44. [PMID: 33973674 DOI: 10.1002/mrm.28798] [Reference Citation Analysis]
87 Sadeghi-Naini A, Sannachi L, Tadayyon H, Tran WT, Slodkowska E, Trudeau M, Gandhi S, Pritchard K, Kolios MC, Czarnota GJ. Chemotherapy-Response Monitoring of Breast Cancer Patients Using Quantitative Ultrasound-Based Intra-Tumour Heterogeneities. Sci Rep. 2017;7:10352. [PMID: 28871171 DOI: 10.1038/s41598-017-09678-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
88 Kwong TC, Hsing M, Lin Y, Thayer D, Unlu MB, Su MY, Gulsen G. Differentiation of tumor vasculature heterogeneity levels in small animals based on total hemoglobin concentration using magnetic resonance-guided diffuse optical tomography in vivo. Appl Opt 2016;55:5479-87. [PMID: 27463894 DOI: 10.1364/AO.55.005479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
89 Gupta L, Besseling RM, Overvliet GM, Hofman PA, de Louw A, Vaessen MJ, Aldenkamp AP, Ulman S, Jansen JF, Backes WH. Spatial heterogeneity analysis of brain activation in fMRI. Neuroimage Clin 2014;5:266-76. [PMID: 25161893 DOI: 10.1016/j.nicl.2014.06.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
90 He S, Sun XJ, Zheng JB, Qi J, Chen NZ, Wang W, Wei GB, Liu D, Yu JH, Lu SY, Wang H. Recombinant lentivirus with enhanced expression of caudal-related homeobox protein 2 inhibits human colorectal cancer cell proliferation in vitro. Mol Med Rep 2015;12:1838-44. [PMID: 25847407 DOI: 10.3892/mmr.2015.3594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
91 Russell MR, D'Amato A, Graham C, Crosbie EJ, Gentry-Maharaj A, Ryan A, Kalsi JK, Fourkala EO, Dive C, Walker M, Whetton AD, Menon U, Jacobs I, Graham RL. Novel risk models for early detection and screening of ovarian cancer. Oncotarget 2017;8:785-97. [PMID: 27903971 DOI: 10.18632/oncotarget.13648] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
92 Beaton L, Bandula S, Gaze MN, Sharma RA. How rapid advances in imaging are defining the future of precision radiation oncology. Br J Cancer 2019;120:779-90. [PMID: 30911090 DOI: 10.1038/s41416-019-0412-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
93 Jansen JF, Lu Y, Gupta G, Lee NY, Stambuk HE, Mazaheri Y, Deasy JO, Shukla-Dave A. Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer. World J Radiol 2016; 8(1): 90-97 [PMID: 26834947 DOI: 10.4329/wjr.v8.i1.90] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
94 Hartmann L, Bundschuh L, Zsótér N, Essler M, Bundschuh RA. Tumor heterogeneity for differentiation between liver tumors and normal liver tissue in 18F-FDG PET/CT. Nuklearmedizin 2021;60:25-32. [PMID: 33142334 DOI: 10.1055/a-1270-5568] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Tirumani SH, Kim KW, Nishino M, Howard SA, Krajewski KM, Jagannathan JP, Cleary JM, Ramaiya NH, Shinagare AB. Update on the role of imaging in management of metastatic colorectal cancer. Radiographics. 2014;34:1908-1928. [PMID: 25384292 DOI: 10.1148/rg.347130090] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
96 Dickie BR, Banerji A, Kershaw LE, McPartlin A, Choudhury A, West CM, Rose CJ. Improved accuracy and precision of tracer kinetic parameters by joint fitting to variable flip angle and dynamic contrast enhanced MRI data. Magn Reson Med 2016;76:1270-81. [PMID: 26480291 DOI: 10.1002/mrm.26013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
97 Secord AA, Nixon AB, Hurwitz HI. The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer. Gynecol Oncol 2014;135:349-58. [PMID: 25178997 DOI: 10.1016/j.ygyno.2014.08.033] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
98 Ferrarotto R, Hoff PM. Antiangiogenic drugs for colorectal cancer: exploring new possibilities. Clin Colorectal Cancer 2013;12:1-7. [PMID: 22763196 DOI: 10.1016/j.clcc.2012.06.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
99 Custodio A, Barriuso J, de Castro J, Martínez-Marín V, Moreno V, Rodríguez-Salas N, Feliu J. Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives. Cancer Treat Rev. 2013;39:908-924. [PMID: 23510598 DOI: 10.1016/j.ctrv.2013.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
100 O'Connor JPB. Cancer heterogeneity and imaging. Semin Cell Dev Biol 2017;64:48-57. [PMID: 27717679 DOI: 10.1016/j.semcdb.2016.10.001] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
101 Bernstein JM, Kershaw LE, Withey SB, Lowe NM, Homer JJ, Slevin NJ, Bonington SC, Carrington BM, West CM. Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer. Oral Oncol 2015;51:508-13. [PMID: 25700703 DOI: 10.1016/j.oraloncology.2015.01.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]